glp 1 drugs and inflammation Do GLP-1 reduce inflammation? Glucagon-like peptide-1: a multi-faceted anti-inflammatory
Description
Discover the U.S
The UK Medicines and Healthcare products Regulatory Agency (MHRA) has today approved a new indication for Wegovy (semaglutide) to reduce the risk of overweight and obese adults suffering serious heart problems or strokes.
Understand their differences in efficacy and safety.
Semaglutide 2.4mg once weekly, a subcutaneously administered GLP-1 RA approved for obesity treatment in 2021, results in 1517% mean weight loss (WL) with evidence of cardioprotection
World Health Organization
The reason
